AFT Pharmaceuticals Ltd.'s market cap is currently AU$265.19M. The company's EPS TTM is AU$0.103; its P/E ratio is 24.13; and it has a dividend yield of 0.60%. AFT Pharmaceuticals Ltd. is scheduled to report earnings on May 26, 2025, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
Income Statement
Total Revenue	$ 195.41M	$ 156.64M	$ 130.31M	$ 113.11M	$ 105.60M
Gross Profit	$ 88.27M	$ 72.98M	$ 61.77M	$ 48.74M	$ 48.27M
Operating Income	$ 24.23M	$ 19.67M	$ 20.39M	$ 10.71M	$ 11.50M
EBITDA	$ 27.72M	$ 20.40M	$ 22.16M	$ 12.43M	$ 11.77M
Net Income	$ 15.61M	$ 10.65M	$ 19.85M	$ 7.78M	$ 12.69M
Balance Sheet
Cash & Short-Term Investments	$ 12.04M	$ 4.75M	$ 7.94M	$ 3.21M	$ 6.12M
Total Assets	$ 165.26M	$ 148.06M	$ 127.32M	$ 105.13M	$ 87.05M
Total Debt	$ 32.19M	$ 38.05M	$ 40.51M	$ 42.22M	$ 47.20M
Net Debt	$ 20.15M	$ 33.30M	$ 32.57M	$ 39.01M	$ 41.08M
Total Liabilities	$ 77.46M	$ 74.80M	$ 65.02M	$ 68.54M	$ 69.80M
Stockholders' Equity	$ 87.80M	$ 73.27M	$ 62.31M	$ 36.59M	$ 17.25M
Cash Flow
Free Cash Flow	$ 19.33M	$ 11.43M	$ 13.82M	$ 657.00K	$ 14.79M
Operating Cash Flow	$ 28.86M	$ 11.63M	$ 14.15M	$ 750.00K	$ 14.88M
Investing Cash Flow	$ -9.53M	$ -9.18M	$ -5.58M	$ -6.23M	$ -6.56M
Financing Cash Flow	$ -10.63M	$ -6.98M	$ -2.28M	$ 2.52M	$ -9.12M

Currency in NZD

AFT Pharmaceuticals Ltd. Earnings and Revenue History

Income Statement >

AFT Pharmaceuticals Ltd. Debt to Assets

Balance Sheet >

AFT Pharmaceuticals Ltd. Cash Flow

Cash Flow >

AFT Pharmaceuticals Ltd. Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing